west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "胡盛寿" 48 results
  • “一站式”复合技术在心血管外科的应用

    “一站式”复合(Hybrid)技术是在同一空间和时间内运用心血管介入与外科手术的复合技术,充分发挥心血管介入治疗和外科手术的优势,治疗复杂的心血管疾病。“一站式”复合技术治疗心血管疾病是当今心脏外科领域中一个全新的治疗理念,其意义在于:以患者为中心,融合多学科的知识和理念,针对患者不同的病理生理状态,设计出最佳的治疗组合方案,从而以最小的代价,获得最佳的疗效。  随着介入治疗技术和外科治疗技术的发展,两种技术的优势和缺陷也逐渐被人们所认识。以先天性心脏病为例,介入治疗尽管得到很大程度的发展,但仍有很大的局限性,如新生儿和小婴儿介入治疗的径路问题。外科治疗仍然是复杂先天性心脏病主要治疗方式,但手术创伤大,并发症多。现代医学的发展要求打破专科的壁垒,真正体现患者至上的原则。因此,联合介入治疗和外科治疗,两种技术的优势互补必将成为未来心血管外科发展的趋势,尤其是“一站式”复合技术手术室硬件条件的具备,使这种技术融合得到更大程度的发挥。 “一站式”复合技术在冠心病、先天性心脏病和大血管疾病方面都得到了很好的应用。冠心病治疗方面,由于乳内动脉旁路移植手术的远期高通畅率得到公认,小切口、胸腔镜辅助或者全内镜下的乳内动脉至左前降支旁路移植手术,经皮冠状动脉内支架植入治疗右冠状动脉和左回旋支动脉,这样的“一站式”复合技术在治疗冠状动脉多支病变取得了很好的疗效,甚至可用于治疗左主干病变。先天性心脏病治疗方面,受血管径路的限制,一些介入治疗在新生儿和小婴儿受到限制,如新生儿和小婴儿室间隔完整的肺动脉闭锁、严重肺动脉狭窄、左心室发育不良综合征等,通过外科手术径路可以安全有效地施行介入治疗。郑哲、李守军等的论文中提及的法洛四联症合并体肺侧支血管形成的治疗也是“一站式”复合技术应用的很好例证。大血管疾病治疗方面,针对A型主动脉夹层的“全主动脉弓置换+支架象鼻技术”和针对B型夹层的全弓置换+远端支架血管植入技术明显提高了手术的安全性和降低术后并发症的发生率。“一站式”复合技术在心血管疾病治疗领域中的应用可降低术后并发症,提高心血管外科手术疗效,节省因并发症导致医疗资源的消耗,而且可使许多高风险患者得到有效的治疗。郑哲、李守军等的“分期和一站式Hybrid手术治疗法洛四联症合并体肺侧支血管形成的疗效比较”一文比较了“一站式”复合技术和传统分期复合技术的疗效。对于合并体肺侧支的紫绀型先天性心脏病,既往的治疗方式包括:术前封堵体肺侧支,封堵后患者快速转送手术室或者等待数天后进行手术治疗;术中尽量寻找并结扎体肺侧支,然后进行手术治疗;手术治疗后,如果出现肺渗出的征象则进行心血管造影和侧支封堵(补救式),如作者所述,这些治疗方式都有一定的缺陷,而“一站式”复合技术则很好地结合介入治疗优势,在外科手术根治的同时处理侧支循环,与传统的方法比较安全有效,更重要的是在医疗资源,如ICU时间、住院时间等方面显示出优势。 “一站式”复合技术的应用真正体现了心血管疾病的整体治疗观念,改变以往心血管外科和心血管介入治疗各行其是的格局,并逐渐呈现具有“杂交”优势的新学科,在心血管疾病的治疗,尤其是对重症、老龄和幼龄患者将发挥巨大的优势。但是,作为一项新的技术或者新的学科,需要更多类似或者前瞻性设计的临床研究验证她的疗效和优势。

    Release date:2016-08-30 06:06 Export PDF Favorites Scan
  • Commentary on series of Chinese expert consensus on surgical treatment of congenital heart diseases

    If one word is used to describe the development of congenital heart disease surgery in China, "hardship" would be the most appropriate. Generations of pioneers have used their ingenuity to overcome obstacles and promoted the development of the discipline. Seventy years of efforts have established the world's largest congenital heart disease treatment system. However, the huge number of potential patients, low early diagnosis rate and over-screening as well as the uneven developed diagnosis and treatment capabilities hinder the future development. The overall improvement of treatment of congenital heart disease in China lies on more efforts from our fellow experts. The publication of the "Chinese expert consensus on surgical treatment of congenital heart diseases" undoubtedly provides theoretical and practical guidance for the improvement of treatment.

    Release date:2021-02-22 05:33 Export PDF Favorites Scan
  • Progress in Surgical Treatment of Secondary Tricuspid Insufficiency

    Abstract: Tricuspid insufficiency founded in the setting of left-sided heart disease is usually secondary tricuspid insufficiency caused by tricuspid valve annular dilation. Some patients had rheumatic tricuspid valve diseases. Tricuspid valve repair rather than valve replacement is recommend for functional tricuspid regurgitation. Linear annuloplasty and ring annuloplasty are two main tricuspid valve repair methods. However, the indications for treatment of secondary tricuspid regurgitation remain controversial. The optimal surgical repair technique to eliminate secondary tricuspid regurgitation remains challenging. In this article, we review the assessment of tricuspid valve lesions, criteria for correction, and surgical management of secondary tricuspid insufficiency.methods. However, the indications for treatment of secondary tricus

    Release date:2016-08-30 05:49 Export PDF Favorites Scan
  • 冠状动脉瘤的诊断与治疗

    冠状动脉瘤是一种少见的心脏病,凡能导致冠状动脉中层结构和功能削弱的因素,均可导致冠状动脉瘤的形成.因此,其临床表现不具有特异性,与单纯冠状动脉狭窄患者的临床表现相似.目前虽然有多种方法可明确诊断,但冠状动脉造影仍为诊断该病的主要方法,其作用不可替代.冠状动脉瘤易发生血栓、栓塞、瘤体破裂和血管痉挛等并发症,预后差,应尽早治疗.手术治疗较药物治疗、介入治疗疗效明确,手术原则是切除冠状动脉瘤,行冠状动脉旁路移植术,并同时处理合并的病变.

    Release date:2016-08-30 06:32 Export PDF Favorites Scan
  • 冠状动脉旁路移植术后围术期心肌缺血

    目的 探讨冠状动脉旁路移植术(CABG)术后出现围术期心肌缺血(PMI)的相关危险因素及其处理措施. 方法 回顾性总结2 680例CABG患者的临床资料,并根据术后是否发生PMI将其分为PMI组(30例)和非PMI组(2 650例),分析CABG后出现PMI的危险因素. 结果 PMI组中11例进行急诊再血管化,其余行主动脉内球囊反搏(IABP)或药物治疗;院内死亡7例,死亡率为23.3%.心绞痛症状缓解22例,心电图完全或部分复原9例,残留心肌梗死改变14例.非PMI组院内死亡58例,死亡率为2.2%.两组死亡率之间比较差别具有显著性意义(χ2=56.04,P=0.001).多因素分析表明,术前无心肌梗死史、冠状动脉弥漫性病变和术中内膜剥脱为相关危险因素.结论 PMI是CABG术后一种比较危险的并发症,严重者可危及生命,及早诊断和适当的治疗尤为重要,对于因旁路血管堵塞造成的PMI,急诊再次血管移植是挽救患者生命的必要措施.

    Release date:2016-08-30 06:32 Export PDF Favorites Scan
  • RESEARCH ON MARROW MESENCHYMAL STEM CELL PROLIFERATION BY COCULTURING WITH SCHWANN CELL

    Objective To evaluate the effect of Schwann cell (SC) on the proliferation of marrow mesenchymal stem cells (MSCs) and provide evidence for application of SC in construction of the tissue engineered vessels.Methods SC and MSCs were harvested from SD rats(weight 40 g). SC were verified immunohstochemically by the S-100 staining, and MSCs were verified by CD 44, CD 105, CD 34 and CD 45. The 3rd passages of both the cells were cocultured in the Transwell system and were amounted by the 3H-TDR integration technique at 1, 3, 5 and 7 days,respectively. The results were expressed by the CPM(counts per minute, CPM) values. However, MSCs on both the layers were served as the controls. The Westernblot was performed to assess the expression of the vascular endothelial growth factor (VEGF), its receptor Flk-1, and the associated receptor neuropilin 1(NRP-1) in SC, the trial cells, and the controls. Results SC had a spindle shape in the flasks, and more than 90% of SC had a positive reaction for the S-100 staining.MSCs expressed CD44 and CD105, and had a negativesignal in CD 34 and CD 45. The CPM values of MSCs in the trial groups were 2 411.00±270.84,3 016.17±241.57,6 570.83±2 848.27 and 6 375.8±1 431.28at 1, 3, 5 and 7 days, respectively. They were significantly higher in their values than the control group (2 142.17±531.63,2 603.33±389.64,2 707.50±328.55,2 389.00±908.01), especially at 5 days (P<0.05). The Western blot indicated that VEGF was expressedobviously in both the SC group and the cocultured MSCs grou,p and was less visible in the control cells. The expressions of Flk-1 and NRP-1 inthe cocultured MSCs were much ber than in the controls. Conclusion SC can significantly promote the proliferation of MSCs when they are cocultured. The peak time of the proliferation effect appeared at 5 days. This effect may be triggered by the up-regulation of VEGF in MSCs, which also leads to the upregulation of Flk-1 and NRP-1 .

    Release date:2016-09-01 09:23 Export PDF Favorites Scan
  • Emergency Coronary Artery Bypass Grafting after Failed Percutaneous Coronary Intervention

    Objective To summarize the experience of emergency coronary artery bypass grafting (CABG) after failed percutaneous coronary intervention. Methods From January 1998 to December 2002, 9 patients underwent emergency CABG after failed percutaneous coronary intervention. The indications of emergency CABG were coronary artery dissection (5 cases)or perforation (2 cases) and acute arterial occlusion (2 cases). The time averaged 2 hours from onset of ischernia to revascularization. The CABG was performed under off-pump bypass in 3 cases and under CPB in 6 cases. The mean graft number was 3. Results There were no hospital death. The mean follow-up was 17 months. No death and angina occurred. The function of New York Heart Association class Ⅰ-Ⅱ were in 8 patients, class Ⅲ in 1 patient. Conclusion Emergency CABG is an effective management for failed percutaneous coronary intervention if the indication is right.

    Release date:2016-08-30 06:26 Export PDF Favorites Scan
  • Progress of Effect of No-touch Technique on Patency Rate of Vein Grafts after Coronary Artery Bypass Grafting

    Coronary artery bypass grafting (CABG) is an effective method for the treatment of coronary heart disease at present. However, there is still a high rate of vein graft occlusion after CABG, which has a serious impact on the short and long-term clinical results. Venous access technique has been considered as an important factor on affecting the long-term patency rate. Compared with harvesting technology of the open saphenous vein harvesting, no-touch technology retained the surrounding tissue and vascular adventitia of great saphenous vein, and it avoided the high pressure of expansion vein. After CABG was performed by using the no-touch technique, the vein grafts obtained a better short and long-term patency rate, but the effect still needs further clinical verification.

    Release date: Export PDF Favorites Scan
  • Experimental Study of Acellular Bovine Pericardium as Ovine Pulmonary Artery Patch

    ObjectiveTo evaluate the feasibility of using acellular bovine pericardium as a viable tissue engineering vascular patch.MethodsFresh bovine pericardium was treated by enzyme detergent cell extraction, then they were used as vascular patches, ovine jugular vein segments were harvested, separated into endothelial and myofibroblast cells, expanded in cell culture, sequentially seeded onto acellular bovine pericardium patches (3cm×3cm). After 7 days of in vitro culture, the autologous cell/patches as experimental group ( n =5) were used to replace partial pulmonary artery wall. Animals were sacrificed at 4, 6, 8, 12 and 24 weeks. The acellular bovine pericardium patches without autologous cells were used as control group ( n =3). Animals were sacrificed at intervals of 4, 12 and 24 weeks. Explanted patches were evaluated by macroscopic and histologic examinations, assayed for calcium, elastin and collagen content.ResultsAll animals were survived without complications of thrombosis and aneurysm before sacrificed; there was no significant difference in calcium content in two groups; elastin ratio assay showed progressive increase over 4 to 24 weeks, similar to normal pulmonary artery wall, suggesting an ongoing tissue remodeling.ConclusionThe acellular bovine pericardium patch with or without autologous cell seeded to a certain extent can be changed into viable vascular wall tissue after being used to replace partial ovine pulmonary artery wall.

    Release date:2016-08-30 06:24 Export PDF Favorites Scan
  • Staging and OneStop Hybrid Approach for Surgical Treatment of Tetralogy of Fallot with Aortopulmonary Collateral Artery

    Objective To improve the operative effects of patients who had tetralogy of Fallot with aortopulmonary collateral arteries (TOF-APCAs) and evaluate the clinical effects of staging and onestop hybrid approach for TOFAPCAs. Methods From January 2003 to December 2007, thirty patients with TOF-APCAs had undergone combined therapy of APCAs embolization and complete surgical repair. Fifteen patients had APCAs embolization therapy before or after TOF radical operation(staging hybrid group ); Fifteen had onestop hybrid treatment(onestop hybrid group). Results Angiography revealed that there were 19 APCAs in staging hybrid group, and of which 15(78%) were embolized successfully. Five cases had complications and one died from respiratory circulating failure. The rest all recovered and discharged. And 22 APCAs were found in one-stop hybrid group, eighteen (82%) of them were embolized successfully. Only one case had pulmonary effusion. The time of hospitalization(median 37 d vs. 22 d, P=0.011),ICU staying(median 7.0 d vs. 4.7 d,P=0.029)and endotracheal intubation(median 131 h vs. 19 h,P=0.009) was obviously longer, and the hospitalization expenses(median 64 101 [CM(159mm]yuan vs. 48 021 yuan, P=0.033)were obviously higher in staging hybrid group than that in one-stop hybrid group.And there was no statistical significance in cardiopulmonary bypass time(P=0.126) and aortic clamping time(P=0.174) between two groups. Conclusion In comparison with traditional staging hybrid approach, one-stop hybrid approach can simplify the operative process for patients who have TOFAPCAs, improve the operative successful rate and cut down expenses.

    Release date:2016-08-30 06:06 Export PDF Favorites Scan
5 pages Previous 1 2 3 4 5 Next

Format

Content